JMIR Publications invites submissions to a new section on “Next-Generation Ambient Intelligence: “Invisible” Monitoring and AI Adoption for Aging-in-Place” in its open access journal JMIR Aging.

A human, an octopus, and a coral could hardly look more different — yet deep inside their cells, their chromosomes still carry recognizable pieces of a genome inherited from an animal ancestor that lived more than 600 million years ago. A study published today in Science Advances by researchers at the University of Vienna maps how those pieces have been reshuffled across the world of animals and reveals that animal genomes evolve along a limited set of irreversible "evolutionary highways". The latest findings provide an important basis for the conservation of animal biodiversity. 

Engineers at the China Ship Scientific Research Center have developed an autoregressive deep-learning framework (VMD-BiGRU-QRNN) that predicts complex dynamic midship bending moments in severe ocean waves. Tested against physical tow-tank data from a 205,000 DWT bulk carrier, the system reached an average R² of 0.9533 and accurately captured high-frequency whipping peaks, providing crucial risk-assessment data to prevent structural catastrophic failures.

Insilico Medicine has announced the program for ARDD 2026, the 13th Aging Research & Drug Discovery Meeting, taking place October 1–3 at the David Rubenstein Treehouse at Harvard University in Boston.

The three-day program will convene global leaders from pharmaceutical and biotechnology companies, academia, clinical medicine, investment, artificial intelligence, scientific publishing and policy. Sessions will span aging biology, therapeutic discovery, clinical development, regulatory strategy, partnering and investment, reflecting the growing maturity of longevity biotechnology.

Insilico Medicine has announced the program for ARDD 2026, the 13th Aging Research & Drug Discovery Meeting, taking place October 1–3 at the David Rubenstein Treehouse at Harvard University in Boston.

The three-day program will convene global leaders from pharmaceutical and biotechnology companies, academia, clinical medicine, investment, artificial intelligence, scientific publishing and policy. Sessions will span aging biology, therapeutic discovery, clinical development, regulatory strategy, partnering and investment, reflecting the growing maturity of longevity biotechnology.

Edo-period “Ogame” (“large jars”) became increasingly standardized over time, developing distinct shapes for everyday and burial use, reports a new archeological study from Institute of Science Tokyo, Japan. Using AI-assisted techniques and geometric morphometrics, the researcher analyzed 243 historic vessels to quantitatively track these changes. The findings provide the first quantitative evidence that major Edo-period historical events influenced not only expensive porcelains production but also everyday ceramics, offering new insights into early modern Japanese society.

An Australian research collaboration has identified several existing TGA‑approved medicines that could help slow brain damage in children with a rare form of dementia—offering hope for faster treatment options.

In a new study published in the prestigious Nature Communications journal, medical researchers used patient-derived brain cells grown in the lab, combined with advanced imaging and artificial intelligence, to rapidly test approved drugs and pinpoint those that improve brain cell health.